Trial Condition(s):

Pelvic Inflammatory Disease

A Trial Comparing Moxifloxacin versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease

Bayer Identifier:

11981

ClinicalTrials.gov Identifier:

NCT00453349

EudraCT Number:

2006-000874-56

Study Completed

Trial Purpose

To assess the efficacy and safety of oral moxifloxacin compared to oral levofloxacin plus oral metronidazole in uncomplicated pelvic inflammatory disease (PID)

Inclusion Criteria
-  Diagnosis of uncomplicated PID based on the absence of pelvic or tubo-ovarian abscess at pelvic ultrasound and/or laparoscopic examination.
Exclusion Criteria
-  Subjects with impaired liver and renal function; known hypersensitivity to study drugs, related compounds or any of the excipients.

Trial Summary

Enrollment Goal
460
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Avelox (Moxifloxacin hydrochloride, BAY12-8039)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Obstetrics & Gynecology Hosp. of Fudan Univ.

Shanghai, China, 200011

Status
Completed
 
Locations

Peking Univ. First Hosp.

Beijing, China, 100034

Status
Completed
 
Locations

Shengjing Hosp. of China Medical Univ.

Shenyang, China, 110004

Status
Completed
 
Locations

National Taiwan University Hospital

Taipei, Taiwan, China, 10002

Status
Completed
 
Locations

Chung Shan Medical University Hospital

Taizung, Taiwan, China, 402

Status
Completed
 
Locations

Mahidol University

Bangkok, Thailand, 10700

Status
Completed
 
Locations

Peking University Third Hospital

Beijing, China, 100083

Status
Completed
 
Locations

West China Hospital, Sichuan University

Chengdu, China, 610041

Status
Completed
 
Locations

2nd Hosp., Chongqing Medical Univ.

Chongqing, China, 400010

Status
Completed
 
Locations

Bunda Hospital

Jakarta, Indonesia

Status
Completed
 
Locations

HanYang University Medical Center

Seoul, South Korea, 133792

Status
Completed
 
Locations

Philippine General Hospital

Manila, Philippines

Status
Completed
 
Locations

Ziauddin Medical University Hospital

Karachi, Pakistan

Status
Completed
 

Trial Design